• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Five commercially available insulin-like growth factor I (IGF-I) assays in comparison to the former Nichols Advantage IGF-I in a growth hormone treated population.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Krebs, Alexander
    Wallaschofski, Henri
    Spilcke-Liss, Elisabeth
    Kohlmann, Thomas
    Brabant, Georg E
    Völzke, Henry
    Nauck, Matthias
    Affiliation
    Institute of Clinical Chemistry and Laboratory Medicine, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany. alexander.krebs@uni-greifswald.de
    Issue Date
    2008
    
    Metadata
    Show full item record
    Abstract
    BACKGROUND: The serum insulin-like growth factor I (IGF-I) level is accepted to diagnose the growth hormone (GH) status. Here, we evaluated the DRG IGF-I 600 ELISA, DSL IGF-I ELISA, IDS OCTEIA IGF-I, Mediagnost IGF-I-ELISA, and the Siemens Immulite 2500 IGF-I in comparison to the former Nichols Advantage IGF-I assay. METHODS: Imprecision was determined by use of a serum pool and commercial control materials. Accuracy was evaluated by means of a method comparison to Nichols in 173 serum samples of GH deficient patients. RESULTS: The Siemens and the IDS IGF-I assays showed the lowest imprecision with coefficients of variation up to 3.6% and 6.9%, respectively. Both correlated best to Nichols (Siemens: y=0.667X+8.8 microg/L, r=0.950; IDS: y=0.527 X+4.6 microg/L, r=0.927) with the lowest dispersion of residuals from a linear equation. The DSL assay had the highest comparability to Nichols (y=1.000 X+35.5 microg/L, r=0.864), but with a considerable scattering. CONCLUSIONS: To yield IGF-I determination comparable to the former Nichols IGF-I, either the Siemens or the IDS assay should be applied, and the results should be converted by a linear method transformation. Where a conversion factor is not desired, the DSL assay should be selected.
    Citation
    Five commercially available insulin-like growth factor I (IGF-I) assays in comparison to the former Nichols Advantage IGF-I in a growth hormone treated population. 2008, 46 (12):1776-83 Clin. Chem. Lab. Med.
    Journal
    Clinical Chemistry and Laboratory Medicine
    URI
    http://hdl.handle.net/10541/65701
    DOI
    10.1515/CCLM.2008.349
    PubMed ID
    19055455
    Type
    Article
    Language
    en
    ISSN
    1434-6621
    ae974a485f413a2113503eed53cd6c53
    10.1515/CCLM.2008.349
    Scopus Count
    Collections
    All Christie Publications
    Endocrinology

    entitlement

    Related articles

    • Evaluation of immunoassays for the measurement of insulin-like growth factor-I and procollagen type III peptide, indirect biomarkers of recombinant human growth hormone misuse in sport.
    • Authors: Abellan R, Ventura R, Pichini S, Pascual JA, Pacifici R, Di Carlo S, Bacosi A, Segura J, Zuccaro P
    • Issue date: 2005
    • Validation of the IDS Octeia ELISA for the determination of insulin-like growth factor 1 in equine serum and tendon tissue extracts.
    • Authors: Lygren T, Schjerling P, Jacobsen S, Berg LC, Nielsen MO, Langberg H, Thomsen PD
    • Issue date: 2013 Jun
    • Serum IGF-I measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population.
    • Authors: Granada ML, Ulied A, Casanueva FF, Pico A, Lucas T, Torres E, Sanmartí A
    • Issue date: 2008 Jun
    • Performance characteristics of the IMMULITE 2000 insulin-like growth factor binding protein-3 assay.
    • Authors: Owen WE, Roberts WL
    • Issue date: 2005 Mar
    • Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
    • Authors: Freda PU, Post KD, Powell JS, Wardlaw SL
    • Issue date: 1998 Nov
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.